The meta-analysis demonstrated that a low level of MUC2 expression was associated with shorter DFS/RFS in patients with CRC (HR, 1.60; 95% CI, 1.21–2.12; P = 0.001; Figure 2(b)). This evidence concerns the gene MUC2 and colorectal carcinoma.